Literature DB >> 4625858

Adjuvant chemotherapy in resectable cancer of the colon and rectum.

C E Grossi, T F Nealon, L M Rousselot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4625858     DOI： 10.1016/s0039-6109(16)39790-0

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN： 0039-6109            Impact factor:   2.741


× No keyword cloud information.
  3 in total

1.  Safety of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection: a randomized, multicenter, prospective, phase III IOCCRC trial (IOCCRC).

Authors:  Rong-Xin Zhang; Jun-Zhong Lin; Jian Lei; Gong Chen; Li-Ren Li; Zhen-Hai Lu; Pei-Rong Ding; Jiong-Qiang Huang; Ling-Heng Kong; Fu-Long Wang; Cong Li; Wu Jiang; Chuan-Feng Ke; Wen-Hao Zhou; Wen-Hua Fan; Qing Liu; De-Sen Wan; Xiao-Jun Wu; Zhi-Zhong Pan
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-28       Impact factor: 4.553

2.  Prevention of recurrent cancer of the large bowel.

Authors:  H Ellis
Journal:  Proc R Soc Med       Date:  1974-09

3.  Suppressive effect of doxorubicin on liver recurrence after resection of colonic VX2 cancer lesions: difference in efficacy according to the injection protocol.

Authors:  M Sakane; Y Tabuchi; Y Saitoh
Journal:  Surg Today       Date:  1993       Impact factor: 2.549
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.